Complementary Alternative Cardiovascular Medicine

Chapter 5 / Vitamin Therapy and CVD 69
20. GISSI-Prevenzione Investigators (Gruppo Italiano per lo Sudio della Sopravvivenze
nell’infarto Miocardico). Dietary supplementation with n-3 polyunsaturated fatty
acids and vitamin E after myocardial infarction: results of the GISSI- Prevenzione
trial. Lancet 1999;354:447–455.
21. MRC/BHF Heart Protection Study Collaborative Group, MRC/BHF Heart Protection
Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation
in a wide range of patients at increased risk of coronary heart disease death:
early safety and efficacy experience. Eur Heart J 1999;20:725–741.
Lancet 2002;360:23–33.
22. Steinberg D. Cinical trials of antioxidants in atherosclerosis: are we doing the right
things? Lancet 1995;349:36–38.
23. Collaborative group of the Primary Prevention Project. Low dose aspirin and vitamin
E in people at cardiovascular risk: a randomized trial in general practice. Lancet
2001;357:89–95.
24. Jialal I, Norkus E, Cristol I, Grundy SM. Beta carotene inhibits the oxidative modifications
of low-density lipoprotein. Biochem Biophys Acta 1991;1086:134–138.
25. Hennekens CH, Buning JE, Manson JE. Lack of effect of long-term supplementation
with beta carotene on the incidence of malignant neoplasms and cardiovascular
disease. N Engl J Med 1996;N334:1145–1149.
26. Omenn GS, Goodman E, Thornquist MD, et al. Effects of a combination of betacarotene
and vitamin A on lung cancer and cardiovascular disease. N Engl J Med
1996;334:1150–1155.
27. van Poppel G, Kardinaal A, Princen H, Kok FJ. Antioxidants and coronary heart
disease. Ann Med 1994;26:429–434
28. Kuller LH, Evans RW. Homocysteine, vitamins and cardiovascular disease. Circulation
1998;98:196–199.
29. Stampfer MJ, Malinow MR, Willett WCE. A prospective study of plasma
homocyt(e)ine and risk of myocardial infarction in US physicians. JAMA
1992;268:877–881.
30. Rimin EB, Willett WC, Hu FB. Folate and vitamin B6 from diet and supplement in
relation to risk of coronary heart disease among women. JAMA 1998;279:359–364.
31. Voutilainen S, Rissanen TH, Virtanen J, Lakka TA, Salonen JT. Low dietary Folate
intake is associated with an excess incidence of acute coronary events. Circulation
2001;103:2674–2680.
32. Food standards: amendment of standards of identity for enriched grain products to
require addition of folic acid. Fed Register 1996;61:8781–8797.
33. Tucker KL, Mahnken B, Wilson PW, Jacques P, Selhub J. Folic acid fortification
of the food supply. Potential benefits and risks for the elderly population. JAMA
1996;276:1879–1885.
34. Malinow MR, Duell PB, Hess DL, Anderson PH, Kruger WD, Phillipson BE,
Gluckman RA, Block PC, and Upson BM. Reduction of plasma homocysteine
levels by breafast cereal fortified with folic acid in patients with coronary heart
disease. N. Engl. J Med. 1998;338:1009–1015.
35. Jacques PF, Selhub J, Boston AG, Wilson PW, Rosenberg IH. The effect of folic
acid fortification on plasma folate and total homocysteine concentrations. N Engl
J Med 1999;340:1449–1454
36. Usui M, Matsuoka H, Miyazaki H, Ueda S, Okuda S, Imaizum T. Endothelial
dysfunction by acute hyperhomocysteinemia restoration by folic acid. Clin Sci
1999;96:235–239.
37. Wilmink HW, Stroes ESG, Erkelens WD, et al. Influence of folic acid on postprandial
endothelial dysfunction. Arterioscl Thromb Vasc Biol 2000;20:185–188.